Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons

Brian J. Wainger(Boston Children's Hospital), Evangelos Kiskinis(Broad Institute), Cassidy Mellin(Boston Children's Hospital), Ole Wiskow(Broad Institute), Steve S.W. Han(Broad Institute), Jackson Sandoe(Broad Institute), Numa P. Perez(Boston Children's Hospital), Luis A. Williams(Broad Institute), Seungkyu Lee(Boston Children's Hospital), Gabriella L. Boulting(Broad Institute), James D. Berry(Massachusetts General Hospital), Robert H. Brown(University of Massachusetts Chan Medical School), Merit Cudkowicz(Massachusetts General Hospital), Bruce P. Bean(Harvard University), Kevin Eggan(Broad Institute), Clifford J. Woolf(Boston Children's Hospital)
Cell Reports
April 1, 2014
Cited by 684Open Access
Full Text

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of the motor nervous system. We show using multielectrode array and patch-clamp recordings that hyperexcitability detected by clinical neurophysiological studies of ALS patients is recapitulated in induced pluripotent stem cell-derived motor neurons from ALS patients harboring superoxide dismutase 1 (SOD1), C9orf72, and fused-in-sarcoma mutations. Motor neurons produced from a genetically corrected but otherwise isogenic SOD1(+/+) stem cell line do not display the hyperexcitability phenotype. SOD1(A4V/+) ALS patient-derived motor neurons have reduced delayed-rectifier potassium current amplitudes relative to control-derived motor neurons, a deficit that may underlie their hyperexcitability. The Kv7 channel activator retigabine both blocks the hyperexcitability and improves motor neuron survival in vitro when tested in SOD1 mutant ALS cases. Therefore, electrophysiological characterization of human stem cell-derived neurons can reveal disease-related mechanisms and identify therapeutic candidates.


Related Papers

No related papers found

Powered by citation graph analysis